SpringWorks Therapeutics, Inc.
SWTXDelisted Jul 1, 2025- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001773427
SpringWorks Therapeutics, Inc. was delisted on Jul 1, 2025; its insiders filed their last Form 4 on Jul 2, 2025; 223 institutions reported holding it in 13F filings for Q2 2025, worth $3.65B in total; Soros Fund Management was the only superinvestor holding it.
13F holders, Q3 2024
Institutional positions in SpringWorks Therapeutics, Inc. as of Sep 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 226
- +19 vs. Q2 2024
- Shares held
- 80.8M
- +9.23M (+12.9%) vs. Q2 2024
- Total value
- $2.59B
- −$106.4M (−3.9%) vs. Q2 2024
- New holders
- 41
- 89 more added
- Sold out
- 22
- 62 more reduced
2 institutions that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting SWTX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 1 | $47 |
| Q1 2026 | 1 | $47 |
| Q4 2025 | 2 | $2.18M |
| Q3 2025 | 3 | $2.16M |
| Q2 2025 | 223 | $3.65B |
| Q1 2025 | 306 | $3.29B |
| Q4 2024 | 216 | $2.92B |
| Q3 2024 | 226 | $2.59B |
| Q2 2024 | 209 | $2.91B |
| Q1 2024 | 217 | $3.85B |
| Q4 2023 | 180 | $2.75B |
| Q3 2023 | 147 | $1.58B |
| Q2 2023 | 142 | $1.82B |
| Q1 2023 | 149 | $1.70B |
| Q4 2022 | 137 | $1.73B |
| Q3 2022 | 148 | $1.80B |
| Q2 2022 | 144 | $1.36B |
| Q1 2022 | 136 | $2.79B |
| Q4 2021 | 144 | $2.82B |
| Q3 2021 | 142 | $2.86B |
| Q2 2021 | 135 | $3.69B |
| Q1 2021 | 137 | $3.23B |
Institutions, Q3 2024
Shares, value and share of portfolio for each institution holding SpringWorks Therapeutics, Inc.; share changes are against Q2 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Voya Investment Management LLC | 729,125 | $23.4M | 0.02% | +92,027+14.4% | Added |
| Ameriprise Financial Inc | 797,877 | $25.6M | 0.01% | +89,494+12.6% | Added |
| Candriam Luxembourg S.C.A. | 845,170 | $27.1M | 0.16% | +323,066+61.9% | Added |
| Bank of America Corp | 861,210 | $27.6M | 0.00% | +74,314+9.4% | Added |
| Principal Financial Group Inc | 918,445 | $29.4M | 0.02% | +464,903+102.5% | Added |
| GW&K Investment Management, LLC | 925,361 | $29.6M | 0.25% | +241,822+35.4% | Added |
| Lord, Abbett & Co. LLC | 1,069,738 | $34.3M | 0.11% | −1,004,232−48.4% | Reduced |
| Capital International Investors | 1,225,667 | $39.3M | 0.01% | +1,225,667 | New |
| Fiera Capital Corp | 1,257,964 | $40.3M | 0.12% | −39,338−3.0% | Reduced |
| Siren, L.L.C. | 1,377,701 | $44.1M | 2.21% | +1,377,701 | New |
| Woodline Partners LP | 1,381,624 | $44.3M | 0.37% | +19,225+1.4% | Added |
| OrbiMed Advisors LLC | 1,390,631 | $44.6M | 0.82% | −316,700−18.5% | Reduced |
| Morgan Stanley | 1,438,635 | $46.1M | 0.00% | +1,112,516+341.1% | Added |
| ArrowMark Colorado Holdings LLC | 1,492,062 | $47.8M | 0.61% | −132,929−8.2% | Reduced |
| Polar Capital Holdings Plc | 1,500,000 | $48.1M | 0.28% | +500,000+50.0% | Added |
| Geode Capital Management, LLC | 1,670,247 | $53.5M | 0.00% | +109,189+7.0% | Added |
| Pictet Asset Management Holding SA | 1,925,918 | $61.7M | 0.07% | +306,076+18.9% | Added |
| Marshall Wace, LLP | 1,961,830 | $62.9M | 0.08% | −371,287−15.9% | Reduced |
| Maverick Capital LtdSuperinvestorMaverick Capital | 2,778,348 | $89.0M | 1.74% | +177,824+6.8% | Added |
| State Street Corp | 3,090,552 | $99.0M | 0.00% | +3,707+0.1% | Added |
| Boxer Capital, LLC | 3,421,541 | $109.6M | 5.38% | 00.0% | Unchanged |
| Price T Rowe Associates Inc | 3,516,418 | $112.7M | 0.01% | −85,816−2.4% | Reduced |
| Deep Track Capital, LP | 3,843,900 | $123.2M | 3.93% | +143,900+3.9% | Added |
| BlackRock, Inc. | 5,941,797 | $190.4M | 0.00% | +5,941,797 | New |
| Vanguard Group Inc | 6,713,278 | $215.1M | 0.00% | +168,865+2.6% | Added |
| FMR LLC | 11,140,946 | $357.0M | 0.02% | +28,555+0.3% | Added |
| Artal Group S.A. | 0 | $0 | 0.00% | −1,313,026−100.0% | Sold out |
| Laurion Capital Management LP | 0 | $0 | 0.00% | −263,340−100.0% | Sold out |
| Cinctive Capital Management LP | 0 | $0 | 0.00% | −130,545−100.0% | Sold out |
| Castleark Management LLC | 0 | $0 | 0.00% | −105,160−100.0% | Sold out |
| Driehaus Capital Management LLC | 0 | $0 | 0.00% | −76,650−100.0% | Sold out |
| Sphera Funds Management Ltd. | 0 | $0 | 0.00% | −70,269−100.0% | Sold out |
| Assenagon Asset Management S.A. | 0 | $0 | 0.00% | −50,978−100.0% | Sold out |
| Algert Global LLC | 0 | $0 | 0.00% | −34,989−100.0% | Sold out |
| FORA Capital, LLC | 0 | $0 | 0.00% | −17,417−100.0% | Sold out |
| Magnetar Financial LLC | 0 | $0 | 0.00% | −13,338−100.0% | Sold out |
| Allianz Asset Management GmbH | 0 | $0 | 0.00% | −8,000−100.0% | Sold out |
| American Century Companies Inc | 0 | $0 | 0.00% | −7,733−100.0% | Sold out |
| Calamos Advisors LLC | 0 | $0 | 0.00% | −7,650−100.0% | Sold out |
| HSBC Holdings PLC | 0 | $0 | 0.00% | −7,357−100.0% | Sold out |
| Pinnacle Associates Ltd | 0 | $0 | 0.00% | −6,920−100.0% | Sold out |
| Pacer Advisors, Inc. | 0 | $0 | 0.00% | −887−100.0% | Sold out |
| Ashton Thomas Private Wealth, LLC | 0 | $0 | 0.00% | −345−100.0% | Sold out |
| SYSTM Wealth Solutions LLC | 0 | $0 | 0.00% | −255−100.0% | Sold out |
| Massmutual Trust Co FSB | 0 | $0 | 0.00% | −86−100.0% | Sold out |
| Itau Unibanco Holding S.A. | 0 | $0 | 0.00% | −32−100.0% | Sold out |
| Innealta Capital, LLC | 0 | $0 | 0.00% | −32−100.0% | Sold out |
| Allworth Financial LP | 0 | $0 | 0.00% | −12−100.0% | Sold out |
| BlackRock Inc. | – | – | – | – | Not filed |
| Institutional & Family Asset Management, LLC | – | – | – | – | Not filed |